Possible scenario
Policy Broadens
25% Chance
The Anthea pledge becomes the first visible award in a broader effort to shift generic and essential medicine production into the United States before 2028 tariffs. This would be a sector-level policy development, but still not a broad macro shock.
Secondary impacts
- Industrials +0.3%
- Healthcare +0.3%
Tickers
- TEVA-2.2%
- VTRS+0.5%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.